Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Jaguar Health, Inc.

< Previous 1 2 3 Next >
News headline image
Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing Way for December 2021 Launch
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
The Merger of Dragon SPAC S.p.A. and Napo EU S.p.A. has Closed
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Italian Government Clears Merger Plan of Dragon SPAC S.p.A. and Jaguar Health's Italian Subsidiary Napo EU S.p.A. for Closing
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. and Dragon SPAC S.p.A.
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
From Jaguar Health, Inc.
Via AccessWire
Topics Death
Tickers JAGX
News headline image
Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Receives "Complete" Letter from FDA for Last of Four Major Technical Sections for the Company's Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
REMINDER: Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Eastern Time
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Closing of Private Placement Priced at a Premium to Market
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
Jaguar Health Appoints Karen Brunke, Ph.D. as Corporate and Business Development EVP and Chip Whitlow as Animal Health Products Marketing Director
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
Jaguar Health Reports Voting Results from 2021 Annual Meeting of Stockholders
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
Jaguar Health Subsidiary Napo Pharmaceuticals Submits Late-Breaking Abstract for Consideration for Presentation at the 2021 IDWeek Annual Meeting
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Subsidiary Napo Pharmaceuticals Signs License Agreement with its Italian Subsidiary, Napo EU S.p.A., to Develop and Commercialize Crofelemer and Lechlemer in Europe
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Subsidiary Announces Completion of Additional Preclinical Study of Lechlemer (NP-300), the Company's Human Drug Product Candidate for Diarrhea Relief from Cholera and Other Acute Infectious Diarrhea
From Jaguar Health, Inc.
Via AccessWire
Topics Death
Tickers JAGX
News headline image
Jaguar Health, Inc. Reports 2021 Second Quarter Financial Results
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
Jaguar Health Announces Time Change for Friday, August 13th Investor Webcast to 8:00 AM Eastern Time
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health to Host Investor Webcast Friday, August 13th at 8:30 AM Eastern Time Regarding Q2 2021 Financials & Business Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, September 3, 2021 and Encourages All Shareholders to Vote
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
REMINDER FROM JAGUAR HEALTH: Innovators with Jane King Interview with Lisa Conte to Air During Jaguar Investor Webcast on Thursday, July 29, 2021 at 8:30 AM Eastern to Provide Business Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces that Innovators with Jane King Interview with Lisa Conte will Air During Jaguar Investor Webcast on Thursday, July 29, 2021 at 8:30 AM Eastern to Provide Business Updates
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Napo EU S.p.A., Jaguar Health's Italian Subsidiary, and Dragon SPAC S.p.A. Announce Close of 8,830,000 Euro Dragon SPAC Financing
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Completion of Investigator-Initiated Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer Patients
From Jaguar Health, Inc.
Via AccessWire
Tickers JAGX
News headline image
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, August 6, 2021 and Encourages All Shareholders to Vote
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
News headline image
Jaguar Health Set to Join Russell Microcap Index
From Jaguar Health, Inc.
Via AccessWire
Topics Derivatives
Tickers JAGX
News headline image
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, July 9, 2021 and Encourages All Shareholders to Vote
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers JAGX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.